EMR - Emerson Electric Co.

EMR - Emerson Electric Co.

Market Overview

• Current Price: $144.83 (as of April 21, 2026)
• Market Cap: $81.39B - $82.48B
• Sector: Electrical Components and Equipment
• Exchange: NYSE

---

Stock Performance

Period	Price Change
1 Day	-1.32%
1 Week	+0.19%
1 Month	+13.02%
YTD	+9.12%

EMR is showing strong momentum over the past month with a 13% gain, though it pulled back slightly in the most recent session.

---

ORTEX Stock Scores (as of April 22, 2026)

Score Type	Rating (0-100)
Total Score	69.4
Growth	74.0
Momentum	55.1
Quality	56.9
Value	41.8

Emerson scores particularly well on Growth (74.0) and has a solid Total Score of 69.4. The stock shows strength in its growth profile and quality metrics, though the value score suggests it may not be deeply undervalued at current levels.

---

Short Interest Data

Metric	Value	Change
Short Interest % of FF	2.28%	Down 12.9% (1 month)
Shares Short	12.64M	Down 11.7% (1 week)
Days to Cover (DTC)	3.96	-
Cost to Borrow	0.42%	Down 5.2% (1 month)
Availability % of SI	1,570.8%	Very high
Utilization	6.06%	Low

Short interest remains very low at just 2.28% of free float and has been declining steadily. The extremely high availability (over 1,500% of current short interest) and low utilization (6.06%) indicate minimal shorting pressure. Cost to borrow is negligible at 0.42%.

---

Options Sentiment

Metric	Value
Put/Call Ratio (PCR)	0.635
20-Day Mean PCR	0.704
Z-Score	-2.07

The PCR of 0.635 is below the 20-day average, with a z-score of -2.07 indicating unusually bullish options sentiment. More calls are being traded relative to puts compared to recent weeks.

---

Fundamental Highlights

Metric	Value
Revenue (TTM)	$18.93B
EBITDA	$5.41B
Net Income	$2.77B
EPS	$6.49
EV/EBITDA	16.2x
Dividend Yield	1.55%

Emerson generates nearly $19B in annual revenue with healthy profitability. The company produces strong operating cash flow of $4.0B and maintains modest capex of $454M.

---

Analyst Coverage

• Analyst Return Potential: +13.35% upside to consensus target
• RSI (14-day): 59.02 (approaching overbought, but not extreme)

---

Upcoming Events

Next Earnings: May 5, 2026 at 8:00 PM UTC (Q2 2026 Results)

---

Summary

EMR is a large-cap industrial with strong growth characteristics and solid quality metrics. The stock has rallied 13% over the past month and shows bullish options positioning. Short interest is minimal and declining. With analysts forecasting 13% upside and earnings due in early May, the stock appears positioned for continued strength, though the recent momentum suggests some caution as it approaches overbought territory technically.

Technical: RSI at 59 (neutral-to-bullish)
Short Squeeze Risk: Very low (minimal short interest)
Options Sentiment: Bullish (low PCR)

---

This is not financial advice. All data is provided for informational purposes only and may contain errors.